Cite
HARVARD Citation
Biemans, V. et al. (n.d.). DOP052 Vedolizumab vs. ustekinumab for Crohn's disease: comparative effectiveness in a real-life observational cohort study (ICC case series). Journal of Crohn's and colitis. pp. S066-S067. [Online].